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Abstract: Prevalence of the metabolic syndrome is now a very serious health problem in Japan 
and a public preventive strategy is essential to reduce morbidity. A systematic interventional 
strategy for the metabolic syndrome remains to be established. In order to address this issue, a 
multi-center study; Japanese Study to Organize Proper lifestyle modiﬁ  cation for the metabolic 
syndrome (J-STOP-MetS), has been established by nine preventive medical centers among 
Rosai hospital groups. This study comprises a cross-sectional study (J-STOP-MetS 1) and a 
prospective randomized control study (J-STOP-MetS 2). J-STOP-MetS 1 examines the causes 
of the metabolic syndrome by means of a questionnaire in a large cohort of patients with the 
metabolic syndrome and control subjects matched for age and sex. J-STOP-MetS 2 examines 
the hypothesis that guidance on lifestyle modiﬁ  cations will help at risk patients to reduce 
abdominal fat and cardiovascular risk factors. The metabolic syndrome patients are randomly 
assigned either to a single visit to a guidance group or multiple visits every two months. The 
individualized guidance is provided by the coordination of physician, trained nurse, dietician and 
exercise trainer. Several parameters are measured before and six months after the ﬁ  rst guidance 
session, including, body weight, waist circumference, blood pressure, several blood markers 
and arterial stiffness. The J-STOP-MetS is the ﬁ  rst large-scale clinical study of the metabolic 
syndrome in Japan and should provide important evidence for the practical management of the 
metabolic syndrome.
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Introduction
The prevalence of obesity in Japan has increased since the 1980s and is observed in 
all age groups of men and in older groups of women (Yoshiike et al 2002; Sakamoto 
2006). Obesity is strongly associated with established cardiovascular risk factors 
such as hypertension, hyperglycemia and dyslipidemia. Metabolic syndrome has 
recently received great interest, as patients with this syndrome are at high risk 
of developing coronary artery disease (Baltali et al 2003; Kip et al 2004). This 
syndrome is characterized by a group of metabolic risk factors occurring in one 
person. These include abdominal fat accumulation, insulin resistance, high blood 
pressure and abnormalities in lipid and glucose metabolism. A recent Japanese 
governmental survey has shown that 45.6% of men and 16.7% of women aged 
between 20 and 74 years have been diagnosed with the metabolic syndrome or have 
a preliminary stage of this condition (see http://www.mhlw.go.jp/houdou/2006/05/
h0508-1a.html). This national increase in obesity, especially in men, is of great 
concern because it will result in a higher morbidity and mortality rate, due to 
atherosclerotic cardiovascular diseases and, as a consequence of this, an increase 
in healthcare costs is inevitable.Vascular Health and Risk Management 2008:4(2) 416
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The imbalance between energy intake and energy 
expenditure has led to increasing obesity. However, determi-
nants of eating behavior or physical activity are very complex. 
Recent studies have shown that stress at work is an important 
risk factor for the metabolic syndrome (Chandola et al 2006), 
and that shift work may increase metabolic risk factors of 
cardiovascular disease (Karlsson et al 2001). These data sug-
gest that unhealthy behavior that predisposes the metabolic 
syndrome is linked to numerous environmental factors.
A public prevention strategy is essential to reduce the 
morbidity of the metabolic syndrome. To achieve this, 
we must clarify factors which could cause the metabolic 
syndrome, since in highly developed country like Japan, 
there may be several unknown environmental risk factors. 
Furthermore, effective guidelines for lifestyle modiﬁ  ca-
tions in the metabolic syndrome remain to be established. 
To address these issues, we have established a multi-center 
study; Japanese Study To Organize Proper lifestyle modiﬁ  ca-
tion for the metabolic syndrome (J-STOP-MetS).
Methods
J-STOP-MetS 1
The J-STOP-MetS 1 is a cross-sectional study that examines 
the possible causes of the metabolic syndrome by means of 
the questionnaire in a large cohort of metabolic syndrome 
patients and a control group of matched healthy subjects at 
least 1000 subjects in each group. Diagnosis of the meta-
bolic syndrome in men is based on new Japanese criteria 
(CEDSMSJ 2005) that includes waist circumference 85 cm 
or over with at least two cardiovascular risk factors, among 
which are high blood pressure (systolic blood pressure 130 
mmHg or diastolic blood pressure 85 mmHg), hypergly-
cemia (fasting blood sugar 110 mg/dL) and dyslipidemia 
(triglyceride 150 mg/dL, or HDL40 mg/dL). Use of 
antihypertensive, antidiabetic or antidyslipidemic agents is 
considered as an indication for each respective risk factor. 
For women, the diagnostic cutoff value for waist circumfer-
ence was set at 90 cm in Japanese criteria but we have used 
80 cm in this study, because recent studies have consistently 
shown that most suitable cutoff level exists at around 80 cm 
(Miyawaki et al 2005; Hara et al 2006). This is consistent 
with Asian criteria (Alberti et al 2005). Waist circumference 
was measured at the umbilical level in the standing position 
by a trained staff member. More than one hundred cases and 
similar number of age and sex matched controls will be at 
least collected at each center.
Exclusion criteria are severe obesity (body mass 
index 35 kg/m2), diabetic patients treated with insulin, 
uncontrolled diabetes (fasting blood glucose 160 mg/dL or 
HbA1c 8.0%), renal failure (plasma creatinine concentra-
tion 1.5 mg/dL), and previous history of cardiovascular 
diseases, cancer or other serious diseases. After written 
informed consent is obtained, each subject is given a detailed 
questionnaire asking questions about their work, degree of 
physical activity in daily life, past and present illness, present 
medications, beverages, dietary and exercise habits, stress 
at work and at home, type A behavior and depression and 
life style characteristics during childhood. Type A behavior 
was assessed by Maeda checklist (Maeda 1985) and the 
degree of masked depression was assessed by a self-rating 
questionnaire for depression (Abe et al 1972). The validity, 
reliability and clinical usefulness of those questionnaire have 
been reported previously (Munakata et al 1998). The ques-
tionnaire was reviewed by all physicians, nurses, dieticians 
and exercise trainers involved in this study beforehand.
These factors are compared between patients with the 
metabolic syndrome and control subjects. The control sub-
jects must have normal waist circumference (90 cm for 
men and 80 cm for women) with normal blood pressure 
(140/90 mmHg), normoglycemia (fasting blood sugar 110 
mg/dL) and normolipidemia (triglyceride 150 mg/dL and 
HDL 40 mg/dL). The control subjects must also not be 
taking antihypertensive, antidiabetic or antidyslipidemic 
agents. Metabolic syndrome patients are recruited from the 
patients found in outpatient clinics of hypertension, diabetes 
or dyslipidemia or from those found in annual health-check 
up of several companies. Age- and sex-matched control was 
recruited from the subjects and fulﬁ  lled the normal criteria 
in annual health-check up.
J-STOP-MetS 2
Outline of the study
The J-STOP-MetS 2 is a prospective randomized study which 
examines the hypothesis that guidance for life style modiﬁ  -
cation will help at risk patients to reduce abdominal fat and 
cardiovascular risk factors (Figure 1). In Japan, such guid-
ance has been usually offered as a one-off, associated with 
annual health check. However, this single guidance approach 
has not yielded good results, as indicated by the increasing 
incidence of obesity. Furthermore, the guidance offered has 
never been standardized. In this study, we examine whether 
the results can be improved by increasing the frequency of 
guidance and offering guidance which is highly standardized 
and individualized.
In our preliminary data, mean body weight of 169 meta-
bolic syndrome patients was 74 ± 10 (SD) kg. Reduction in Vascular Health and Risk Management 2008:4(2) 417
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mean body weight following a single guidance session in this 
group was 1.3 kg (1.8%). If by repeated guidance we could 
reduce body weight by 5%, the sample size needed to detect 
the difference between the single and multiple guidance 
groups is estimated at 180 per group, allowing for a 20% 
to 30% drop out. The diagnostic criteria for the metabolic 
syndrome in J-STOP-MetS 2 are same as the J-STOP-MetS 
1 study, however, only untreated patients are included. Exclu-
sion criteria are also same in both studies. Unmedicated meta-
bolic syndromes are recruited from the patients occasionally 
found in annual health check up or from outpatients referred 
for further examination of hypertension, diabetes or dyslipid-
emia. The advertisement on the recruitment of the examinee is 
announced in the health promotion lecture for general persons 
or in the magazine for health promoter of companies.
After written informed consent is obtained, the patients 
are given the same questionnaire as used in the J-STOP-
MetS 1. The subjects visit each center after overnight fast. 
After the measurements of height, body weight, and waist 
circumference, blood samples are collected from antecubital 
vein for determination of glucose and lipid proﬁ  les, uric acid 
concentration, renal and liver functions. In the subjects agree 
to participate in a substudy some additional blood is with-
drawn to measure several adipocytokines such as adiponectin 
and C-reactive protein, both of them have been reported to 
be related to atherosclerosis in metabolic syndrome (Haffner 
2006; Okamoto et al 2006). Blood pressures are measured 
by standard mercury sphygmomanometer with the subjects 
in the sitting position after a rest of at least 5 minutes. The 
mean of the two measurements is used for the analysis. Heart 
rate is measured by palpation method. Arterial stiffness as 
assessed by brachial-ankle pulse wave velocity (baPWV) and 
ankle-brachial pressure index (ABI) are measured by new 
device (form PWV/ABI, colin, Japan) in the supine position. 
Validity, reliability and clinical usefulness of the baPWV and 
ABI measured by this machine have been reported elsewhere 
(Cortez-Cooper et al 2003; Munakata et al 2003). Recent 
study has shown that metabolic syndrome detection status 
is closely linked to arterial stiffness as assessed by the bra-
chial ankle pulse wave velocity (Tomiyama 2006). So it is 
of interest if standardized intervention of weight loss could 
reduce arterial stiffness in metabolic syndrome.
Body composition (fat free mass and fat mass in whole 
body and at each limb) is measured by eight polar bioelec-
trical impedance analysis (In body 720, Biospace, Korea). 
The principle of this measurement has been reported previ-
ously (Bedogni et al 2002). Accuracy of this method for the 
assessment of total and appendicular body composition has 
been reported in healthy human (Malavolti et al 2003) and 
peritoneal dialysis patients (Medici et al 2005).
Intervention program
Three essential components of a weight control program 
are diet, exercise, and behavioral modifications. Total, 
Figure 1 J-STOP-MetS 2 protocol.
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individualized life style modiﬁ  cation is given to all subjects 
as follows. First of all, the physician explains the pathophysi-
ology of the metabolic syndrome and the risk of future cardio-
vascular events of this condition. The physician also explains 
the rationale for advising weight loss and its importance for 
the maintenance of health. The subjects must be strongly 
motivated to participate in a weight reduction program by 
the physicians’ introduction.
Then behavioral approach was conducted by a trained 
nurse to maintain a long-term weight loss. Behavioral therapy 
involves 1) recognition of unhealthy dietary habits (night 
meal, between meals, excess alcohol consumption, absence 
of breakfast, etc), 2) record-keeping of body weight, waist 
circumference, and physical activity, 3) stimulus control (ie, 
attention to antecedents of eating that promote excessive 
intake), 4) cognitive restructuring, and 5) smoking cessation 
if needed. Tentative goal of weight reduction is set at 5% of 
body weight during the next 2 months.
The dietician, then, gives advice on what is an adequate 
calorie intake to achieve the goal. Weight loss occurs only 
when energy expenditure exceeds intake. One must know 
the amount of energy intake keeps the body weight constant. 
The dietary program, thus, is based on the caloric reduction 
of about 400 to 600 kcal/day from the value necessary to 
maintain weight. For example, a kilogram of adipose tissue 
provides the energy equivalent of 7000 kcal (Munro and 
Douglas 1983). So, the reduction of 5 kilogram of adipose 
tissue during 2 months can be achieved by negative calo-
rie intake of 583 kcal/day (7000 kcal × 5 kg/60 day). The 
diet also should have the following characteristics: 1) satis-
faction of all nutrient needs except energy, 2) practicality and 
long-term effectiveness (ie, the diet should be both practical 
for and applicable to the patient’s environment, and should 
be conductive to weight maintenance, and 3) recommenda-
tion of salt restriction and DASH food (Sacks et al 2001) for 
subjects with high blood pressure.
As part of weight-control program, the exercise component 
is useful and should 1) promote increased energy expenditure, 
2) promote fat loss and maintenance of lean body mass, 3) be 
safe for participating individuals, and 4) promote increases in 
physical activity levels within the individual’s life-style. So, 
the exercise trainer examines the subjects’ physical conditions 
and conducts an ergometer test to determine the safety level 
of daily exercise, based on cardiopulmonary responses to 
exercise. The goal of increase in physical activity is at least 
30 minutes per day, 4 to 5 days per week. Exercise intensity is 
moderate at approximately 40% to 55% of heart rate reserve, 
and consisted primarily of brisk walking.
Randomization
After the ﬁ  rst guidance, subjects are assigned either to a single 
guidance group or a multiple guidance group (Figure 1). 
Subjects assigned to a multiple guidance group visit each center 
every 2 months and receive reevaluation of body weight, weight 
circumference and body composition. The goal of body weight 
reduction at next visit in multiple guidance group is a further 
5% reduction of the body weight. If target body weight is not 
achieved at each visit, the cause is evaluated by the interview of 
the trained nurse, dietician and exercise trainer, and the adequate 
advise is presented to the subjects. Subjects assigned to a single 
guidance group are requested to practice weight reduction 
program at a rate of 5% of body weight every 2 month.
Outcome measures
Outcome measures are body weight, waist circumference, 
lean body mass, and fat mass, several biochemical markers in 
the blood (glucose, lipid proﬁ  les, liver, and renal functions), 
and arterial stiffness as assessed by the brachial-ankle pulse 
wave velocity. Those are studied before and 6 months after 
the ﬁ  rst guidance in all subjects.
This study was approved by the ethic committee of all 
Rosai Hospitals participated in this study.
Discussion
A recent Japanese governmental survey has shown that the 
metabolic syndrome is very prevalent in all adult generations 
of men and in older women. It is important that greater 
effort is made to prevent further increases of the metabolic 
syndrome in the population and to achieve this aim, a public 
preventive strategy is required.
Excess calorie intake and low energy expenditure can both 
be causes of the metabolic syndrome. In Japan, westernization 
of food, which is rich in lipid, and reduced physical activity 
due to a motorization, are believed to have contributed to 
an obesity-prone lifestyle (Yazaki and Kadowaki 2006). 
However, it has been suggested that environmental factors can 
also signiﬁ  cantly inﬂ  uence the development of the metabolic 
syndrome. For example, Chandola and colleagues (2006) have 
shown that stress at work is a risk factor for the metabolic 
syndrome independent of energy intake and physical activity. 
Furthermore, it has been shown that longer shift work duration 
is associated with a higher risk of metabolic abnormality 
(Karlsson et al 2001). In Japan, the frequency of shift work is 
increasing dramatically (Munakata et al 2001). Moreover, a 
governmental survey has shown that the frequency of workers 
who report job stress in 2004 was 61.5%, which is 6.5% higher 
than in 1987. The causes of the metabolic syndrome must be Vascular Health and Risk Management 2008:4(2) 419
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examined not only from individual dietary and exercise habits 
but also in the context of environmental factors.
J-STOP-MetS 1 is the largest study undertaken to exam-
ine the background of the metabolic syndrome in Japan. The 
outcome of this study will help identify several unrecognized 
risk factors for the metabolic syndrome and this information 
will be used to develop a public preventive strategy aimed 
at reducing the incidence of the metabolic syndrome in the 
Japanese population.
The incidence of obesity is increasing in Japan, despite 
annual health checks. This is possibly because a systematic 
educational system has been lacking as part of the health 
check system. Therefore, to effectively reduce morbidity 
from the metabolic syndrome, we must establish an effective 
educational system.
From a practical point of view, the frequency of guidance 
is very important and should be kept to a minimum, to offset 
absence from work. In diabetes prevention program guidance 
was given 16 times during 6 months (DPPRG 2002), which 
is too frequent for workers because they must be absent more 
than 2 days every month. Also the curriculum was taught by 
case managers in the diabetes prevention program. In this 
study a single guidance is delivered by the coordination of 
highly qualiﬁ  ed staff, including a physician, trained nurse, 
dietician, and exercise professional, in order to improve 
the quality of guidance and to reduce the total number of 
guidance sessions needed.
The cutoff value for waist circumference in the diagnosis 
of the metabolic syndrome is debatable, especially for 
women. Recent studies have shown that the cutoff value 
for women, which has been set at 90 cm for Japanese 
women, would be more appropriate if shortened to 80 cm 
(Miyazaki et al 2005; Hara et al 2006). Although it has been 
shown that waist circumference corresponding to 100 cm2 
of visceral fat area in Japanese women is 92.5 cm (ECCODJ 
2002), the cutoff value must be reduced for small women. 
For such patients, the risk assessment should be done by 
assessing the constellation of cardiovascular risks rather 
than waist circumference alone. Otherwise, a considerable 
number of pseudo-negative cases will occur. In this study, 
therefore, we use the Asian criteria for the diagnosis of the 
metabolic syndrome in women.
It has been shown that compared with usual care, dietary 
counseling interventions produce modest weight loss, which, 
however, diminishes over time (Dansinger et al 2007). So it 
is of particular interest as to how long the effect of our com-
prehensive weight loss program lasts. To address this issue, 
we need to add further long-term follow up study.
Finally, the J-STOP-Mets 2 includes several sub-studies 
which provide scientiﬁ  c merit in their own right. These 
include the effects of lifestyle modiﬁ  cation on arterial 
stiffness and adipocytokines such as high sensitive C-
reactive protein and adiponectin. Recently it has been 
shown that inﬂ  ammation is involved in the stiffening of 
the artery (Okamura et al 2004). Because adeponectin 
has been reported to serve anti-inﬂ  ammatory action, our 
study should clarify the mechanisms why visceral fat 
accumulation increases the arterial stiffness from the view 
of inﬂ  ammation.
In conclusion, the J-STOP-MetS is a ﬁ  rst large-scale 
clinical study on the metabolic syndrome in Japan. In 2008, 
a new law on the management of the metabolic syndrome 
will be in force. We are obligated to give guidance for 
lifestyle modiﬁ  cations to all patients diagnosed with the 
metabolic syndrome at the time of their annual health 
check. Our study should provide several items of evidences 
that will be useful for the practical management of the 
metabolic syndrome and should help with the development 
of a governmental strategy to reduce morbidity of the 
metabolic syndrome.
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